Quantinno Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.44M Buy
49,724
+1,819
+4% +$44.7K ﹤0.01% 2481
2026
Q2
$1.03M Buy
47,905
+6,367
+15% +$97.5K ﹤0.01% 2538
2026
Q1
$577K Buy
41,538
+700
+2% +$11.2K ﹤0.01% 2609
2025
Q4
$663K Buy
40,838
+2,716
+7% +$44.3K ﹤0.01% 2134
2025
Q3
$570K Buy
38,122
+7,611
+25% +$92.7K ﹤0.01% 1891
2025
Q2
$355K Buy
30,511
+8,534
+39% +$77.5K ﹤0.01% 1900
2025
Q1
$163K Buy
21,977
+5,289
+32% +$40.6K ﹤0.01% 1932
2024
Q4
$100K Buy
+16,688
New +$92K ﹤0.01% 1617

Other funds holding ADPT

Quantinno Capital Management's ADPT Position: Q3 2026 in Review

Quantinno Capital Management increased its Adaptive Biotechnologies (ADPT) stake by 3.8% in Q3 2026, buying an estimated $44.7K and bringing the position to 49,724 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2481.

Quantinno Capital Management first reported a position in ADPT in Q4 2024 and has held it in 8 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Quantinno Capital Management held 49,724 shares of Adaptive Biotechnologies worth $1.44M as of Q3 2026.
  • Quantinno Capital Management bought 1,819 Adaptive Biotechnologies shares in Q3 2026, an estimated $44.7K.
  • Adaptive Biotechnologies made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2481 holding.
  • Quantinno Capital Management first reported a position in Adaptive Biotechnologies in Q4 2024 and has held it in 8 quarters since.
  • 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.